(Q42212086)

18 October 2017

Treatment of cutaneous T cell lymphoma with 2'-deoxycoformycin (pentostatin). (English)

1 reference

cutaneous T cell lymphoma

18 October 2017

1 reference

Dang-Vu AP

1

1 reference

18 October 2017

Olsen EA

2

1 reference

18 October 2017

Vollmer RT

3

1 reference

18 October 2017

Greenberg ML

4

1 reference

18 October 2017

Hershfield MS

5

1 reference

18 October 2017

language of work or name

English

0 references

publication date

1 October 1988

1 reference

Journal of the American Academy of Dermatology

18 October 2017

1 reference

18 October 2017

19

1 reference

18 October 2017

4

1 reference

18 October 2017

692-698

1 reference

Cutaneous T cell lymphoma

18 October 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2888%2970224-8

7 January 2021

Isotretinoin and cutaneous helper T-cell lymphoma (mycosis fungoides)

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2888%2970224-8

7 January 2021

Treatment of cutaneous T-cell lymphoma by extracorporeal photochemotherapy. Preliminary results

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2888%2970224-8

7 January 2021

A STUDY OF THE TISSUE DISTRIBUTION OF ADENOSINE DEAMINASE IN SIX MAMMAL SPECIES

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2888%2970224-8

7 January 2021

Mechanisms of deoxyadenosine toxicity in human lymphoid cells in vitro: relevance to the therapeutic use of inhibitors of adenosine deaminase

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2888%2970224-8

7 January 2021

Correlation of adenosine deaminase activity with cell surface markers in acute lymphoblastic leukemia

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2888%2970224-8

7 January 2021

Inhibitors of adenosine deaminase

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2888%2970224-8

7 January 2021

Effectiveness of pentostatin (2'-deoxycoformycin) in refractory lymphoid neoplasms

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2888%2970224-8

7 January 2021

Deoxycoformycin in the treatment of leukemias and lymphomas

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2888%2970224-8

7 January 2021

Low-dose deoxycoformycin in lymphoid malignancy

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2888%2970224-8

7 January 2021

Adenosine metabolism in phytohemagglutinin-stimulated human lymphocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2888%2970224-8

7 January 2021

Resistance of an adenosine kinase-deficient human lymphoblastoid cell line to effects of deoxyadenosine on growth, S-adenosylhomocysteine hydrolase inactivation, and dATP accumulation

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2888%2970224-8

7 January 2021

ATP depletion as a consequence of adenosine deaminase inhibition in man.

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2888%2970224-8

7 January 2021

Conversion of a stem cell leukemia from a T-lymphoid to a myeloid phenotype induced by the adenosine deaminase inhibitor 2'-deoxycoformycin

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2888%2970224-8

7 January 2021

10.1016/S0190-9622(88)70224-8

Identifiers

DOI

1 reference

18 October 2017

1 reference